Clare Ozawa
Clare R. Ozawa, PhD has served as a member of our board of directors since May 2017. Dr. Ozawa has served as a Managing Director at Versant Venture Management, LLC, a life science venture capital firm investing in early stage healthcare companies, since July 2017 and was an investment professional at Versant from 2008 to 2011.
Contact
- Social accounts: linkedin
Companies
Company
Roles
858 Therapeutics
858 Therapeutics develops small molecule drugs targeting oncology and immunology.
Board Member
Oyster Point Pharmaceuticals
Ophthalmology Indications
Board Member
Versant Ventures
A venture capital and private equity firm investing companies focused on the discovery and development of novel therapeutics, medical devices and diagnostics.
Board Member